Shenzhen Hepalink Pharmaceutical Group Market Cap

Shenzhen Hepalink Pharmaceutical Group has a market cap or net worth of 14.39 billion as of January 30, 2025. Its market cap has decreased by -14.46% in one year.

Market Cap

14.39B

Enterprise Value

15.79B

Revenue

6.04B

Ranking

n/a

PE Ratio

n/a

Stock Price

3.88

Market Cap Chart

Since May 6, 2010, Shenzhen Hepalink Pharmaceutical Group's market cap has decreased from 79.74B to 14.39B, a decrease of -81.95%. That is a compound annual growth rate of -10.97%.

Market Cap History

Date	Market Cap	% Change
Jan 27, 2025	14.39B	-4.42%
Dec 31, 2024	15.06B	-10.92%
Dec 29, 2023	16.91B	-12.50%
Dec 30, 2022	19.32B	-30.93%
Dec 31, 2021	27.97B	-0.50%
Dec 31, 2020	28.11B	3.27%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	186.95B
Hansoh Pharmaceutical Group Company	105.39B
JD Health International	99.64B
WuXi Biologics	75.63B
Sinopharm Group	63.97B
Alibaba Health Information Technology	55.64B
Innovent Biologics	54.06B
Akeso	53.67B

Market Cap Rankings